
Genexine
Clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics.
Market cap
$181m
Enterprise value
$226m
Share price
KRW4870.00 095700.KQ
Recent deals
Authorizing premium user...
Clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics.